Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms

被引:0
|
作者
Lim, Ken-Hong [1 ,2 ]
Matsuura, Shinobu [3 ]
Xu, Bing [4 ,5 ,6 ]
机构
[1] MacKay Mem Hosp, Dept Internal Med, Div Hematol & Oncol, Taipei, Taiwan
[2] MacKay Med Coll, Dept Med, New Taipei, Taiwan
[3] Boston Univ, Sch Med, Dept Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA
[4] Xiamen Univ, Affiliated Hosp 1, Dept Hematol, Xiamen, Peoples R China
[5] Xiamen Univ, Inst Hematol, Sch Med, Xiamen, Peoples R China
[6] Key Lab Xiamen Diag & Treatment Hematol Malignanc, Xiamen, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
myeloproliferative neoplasms; chronic myeloid leukemia; CALR; MPL; tyrosine kinase inhibitor; THROMBOPOIETIN RECEPTOR; CALRETICULIN; ACTIVATION;
D O I
10.3389/fonc.2021.762928
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Treatment strategies for myeloproliferative neoplasms
    Heidel, Florian
    ONKOLOGIE, 2022, 28 (08): : 721 - 730
  • [2] Innovative treatment strategies in myeloproliferative neoplasms
    Doehner, K.
    Stegelmann, F.
    Schlenk, R. F.
    ONKOLOGIE, 2011, 34 : 36 - 36
  • [3] Innovative treatment strategies in Myeloproliferative Neoplasms
    Doehner, K.
    Stegelmann, F.
    Griesshammer, M.
    Schlenk, R. F.
    ONKOLOGIE, 2012, 35 : 84 - 84
  • [4] Extramedullary hematopoiesis in myeloproliferative neoplasms: Pathophysiology and treatment strategies
    Chernak, Brian J.
    Rampal, Raajit K.
    CELLULAR AND MOLECULAR ASPECTS OF MYELOPROLIFERATIVE NEOPLASMS - PT A, 2021, 365 : 97 - 116
  • [5] Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies
    John Mascarenhas
    Nitin Roper
    Pratima Chaurasia
    Ronald Hoffman
    Clinical Epigenetics, 2011, 2 : 197 - 212
  • [6] Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies
    Mascarenhas, John
    Roper, Nitin
    Chaurasia, Pratima
    Hoffman, Ronald
    CLINICAL EPIGENETICS, 2011, 2 : 197 - 212
  • [7] Novel insights into the biology and treatment of chronic myeloproliferative neoplasms
    Mughal, Tariq I.
    Barbui, Tiziano
    Abdel-Wahab, Omar
    Kralovics, Robert
    Jamieson, Catriona
    Kvasnicka, Hans-Michael
    Mullaly, Ann
    Rampal, Raajit
    Mesa, Ruben
    Kiladjian, Jean-Jacques
    Deininger, Michael
    Prchal, Josef
    Hehlmann, Ruediger
    Saglio, Giuseppe
    Van Etten, Richard A.
    LEUKEMIA & LYMPHOMA, 2015, 56 (07) : 1938 - 1948
  • [8] Novel therapeutics in myeloproliferative neoplasms
    Sangeetha Venugopal
    John Mascarenhas
    Journal of Hematology & Oncology, 13
  • [9] Novel therapeutics in myeloproliferative neoplasms
    Venugopal, Sangeetha
    Mascarenhas, John
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [10] Comparison of Different Treatment Strategies for Blast-Phase Myeloproliferative Neoplasms
    Tokumori, Franco Castillo
    Al Ali, Najla
    Chan, Onyee
    Sallman, David
    Yun, Seongseok
    Sweet, Kendra
    Padron, Eric
    Lancet, Jeffrey
    Komrokji, Rami
    Kuykendall, Andrew T.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (07): : E521 - E525